Key Takeaways:
- Mathieu Cortyl appointed as CEO of Tonisity International Limited, effective December 4, 2024.
- Cortyl has over eight years of experience at Tonisity, previously serving as Managing Director across multiple global regions.
- Arie Halpern steps down as CEO after nearly a decade and will transition to the role of Executive Chairman.
- Tonisity aims to expand its product offerings for young ruminants and strengthen its presence in new markets, including Central America and the Middle East.
Leadership Transition
Tonisity International Limited (Profile), a leader in animal nutrition solutions, has announced the appointment of Mathieu Cortyl as its new Chief Executive Officer (CEO), effective December 4, 2024. Cortyl steps into the role after a significant tenure at Tonisity, where he played a critical part in the company’s global growth and operations.
With over eight years at Tonisity, Mathieu Cortyl served as Managing Director for Europe, the Asia Pacific region, Africa, and South America. During this time, he was instrumental in establishing the company’s global distribution network and building its sales and marketing teams.
Vision for Growth
Commenting on his appointment, Mathieu Cortyl stated: “I am honoured to take on this new role and lead Tonisity into its next phase of growth. Tonisity has built a reputation for innovation and quality in animal nutrition, and I am excited to work with our talented team and partners to continue delivering value for our customers and stakeholders. Together, we will drive Tonisity forward as a global leader in the industry.”
Mathieu succeeds Arie Halpern, who has served as Tonisity’s CEO for nearly a decade. Halpern will remain actively involved in the company’s strategic direction as Executive Chairman.
Halpern expressed confidence in Mathieu’s leadership, stating: “Mathieu’s leadership, vision, and commitment to Tonisity’s mission make him the ideal choice to take the company forward. I am confident he will continue to build on our success and lead Tonisity into a bright future, and I look forward to continuing to work on the Tonisity team in a senior leadership role as Executive Chairman.”
Tonisity International Latest News
Peer-Reviewed Study Highlights Effectiveness of Tonisity Px Against Porcine Epidemic Diarrhea Virus (2024/05/02)
Tonisity International Limited, an Ireland-based animal health and nutrition company, recently highlighted a study involving their flagship product, Tonisity Px. The study, published in the Veterinary Immunology and Immunopathology journal, showed that Tonisity Px reduced Porcine Epidemic Diarrhea Virus (PEDV) shedding in piglets and improved their overall intestinal health. The product is registered across multiple continents and has potential for broader applications in improving animal health and managing disease.
Read the complete study here.
Gains Health Canada Approval to Enter Canadian Swine Market (2024/04/30)
Tonisity International has received approval from Health Canada to import and distribute Tonisity Px and PxW products in Canada. These products target swine production challenges such as improving piglet survival rates and optimizing growth. The patented isotonic protein drink, Tonisity Px, enhances nutrient absorption and overall health in piglets, leading to higher weight gains, reduced mortality, and a decreased need for medications. Tonisity is committed to research, as evidenced by nearly 235 swine trials conducted globally, proving the efficacy of its products.
Photo by Amber Kipp on Unsplash
1 Comment